Stifel Financial Corp Has $1.20 Million Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Stifel Financial Corp reduced its position in Option Care Health, Inc. (NASDAQ:OPCH) by 4.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 38,315 shares of the company’s stock after selling 1,734 shares during the period. Stifel Financial Corp’s holdings in Option Care Health were worth $1,199,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in OPCH. GAMMA Investing LLC grew its stake in shares of Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after buying an additional 471 shares in the last quarter. Lindenwold Advisors INC lifted its stake in Option Care Health by 5.4% in the third quarter. Lindenwold Advisors INC now owns 9,548 shares of the company’s stock valued at $299,000 after acquiring an additional 489 shares during the last quarter. Trust Point Inc. grew its position in Option Care Health by 2.6% in the third quarter. Trust Point Inc. now owns 24,124 shares of the company’s stock worth $755,000 after acquiring an additional 622 shares in the last quarter. Nisa Investment Advisors LLC increased its stake in shares of Option Care Health by 5.4% during the 2nd quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company’s stock worth $376,000 after purchasing an additional 690 shares during the last quarter. Finally, KBC Group NV raised its holdings in shares of Option Care Health by 16.2% during the 3rd quarter. KBC Group NV now owns 5,013 shares of the company’s stock valued at $157,000 after purchasing an additional 700 shares in the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Price Performance

Shares of NASDAQ:OPCH opened at $22.91 on Monday. The company has a market cap of $3.90 billion, a price-to-earnings ratio of 19.25, a PEG ratio of 2.43 and a beta of 1.33. The business has a 50 day moving average price of $24.82 and a 200 day moving average price of $28.23. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $34.63.

Insider Transactions at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the company’s stock in a transaction dated Friday, November 8th. The shares were bought at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now owns 326,334 shares in the company, valued at $7,355,568.36. This trade represents a 15.18 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.64% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Truist Financial decreased their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, November 1st. UBS Group started coverage on Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price objective on the stock. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Finally, Barrington Research dropped their price target on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research report on Thursday, October 31st. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, Option Care Health presently has an average rating of “Hold” and a consensus target price of $30.14.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.